Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage

Transfusion

Volumn 36, Issue 1, 1996, Pages 21-28

  Federowicz, I ^a,b   Barrett, B B ^b   Andersen, J W ^b   Urashima, M ^b   Popovsky, M A ^c   Anderson, K C ^b,d  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEVER; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

EID: 0030022407     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36196190511.x     Document Type: Article

References (44)

1. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
2. 10 white cell-reduction filters for red cells. Transfusion 1992;32:129-33
3. Dzik S. Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev 1993;7:65-77.
4. Dzik S. Prestorage leukocyte reduction of cellular blood components. Transfus Sci 1994;15:131-9.
5. Blajchman MA, Bardossy L, Carmen RA, et al. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blood 1992;79:1371-5.
6. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344-8.
7. Buchholz DH, AuBuchon JP, Snyder EL, et al. Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 1994;34:852-7.
8. Novotny VM, van Doorn R, Witvliet MD, et al. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood 1995;85:1736-41.
9. Ledent E, Berlin G. Inadequate white cell reduction by bedside filtration of red cell concentrates. Transfusion 1994;34:765-8.
10. Williamson LM, Wimperis JZ, Williamson R et al. Bedside filtration of blood products in the prevention of HLA alloimmunization - a prospective randomized study. Blood 1994;83:3028-35.
11. Dzik WH, Cusack WF, Sherburne B, Kickler T. The effect of prestorage white cell reduction on the function and viability of stored platelet concentrates. Transfusion 1992;32:334-9.
12. Sweeney JD, Holme S, Stromberg RR, Heaton WAL. In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35:125-30.
13. Brubaker DB. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 1990;30:733-7.
14. Ferrara JLM. The febrile platelet transfusion reaction: a cytokine shower (editorial). Transfusion 1995;35:89-90.
15. Anderson KC, Gorgone BC, Wahlers E, et al. Preparation and utilization of leukocyte poor apheresis platelets. Transfus Sci 1991;12:163-70.
16. Menitove JE, McElligott MC, Aster RH. Febrile transfusion reaction: what blood component should be given next? Vox Sang 1982;42-318-21.
17. Mangano MM, Chambers LA, Kruskall MS. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 1991;95:733-8.
18. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7.
19. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
20. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
21. Dzieczkowski JS, Barrett BB, Nester D, et al. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 1995;35:20-5.
22. Popovsky MA, Tremblay C, Chopek M, Arnold N. Consistency of pre-storage leukocyte removal (abstract). Transfusion 1994;34(Suppl):S27.
23. Lutz P, Dzik WH. Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion 1993;33:409-12.
24. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228-33.
25. Urashima M, Chauhan D, Uchiyama H, et al. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995;85:1903-12.
26. Cox DR, Oakes D, eds. Analysis of survival data. New York: Chapman & Hall, 1984.
27. Bontadini A, Fruet F, Tazzari PL, et al. Comparative analysis of six different white cell-reduction filters for packed red cells. Transfusion 1994;34:531-5.
28. Kao KJ, Mickel M, Braine HG, et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. Transfusion 1995;35:13-9.
29. Farrugia A, Tan Y, Romeo A, et al. Relative efficiency of leucocyte removal procedures for the production of leucocyte-poor red cell concentrates assessed by flow cytometry. Vox Sang 1994;66:153-60.
30. Andreu G, Dewailly J. Prevention of HLA alloimmunization by using leukocyte-depleted components. Curr Stud Hematol Blood Transfus 1994;60:29-40.
31. Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, et al. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. Blood 1995;85:824-8.
32. Al EJM, Visser SCE, Prins HK, et al. A flow cytometric method for determination of white cell subpopulations in filtered red cells. Transfusion 1991;31:835-42.
33. Lee TH, Stromberg RR, Heitman J, et al. Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. Transfusion 1994;34:986-94.
34. Rebulla P, Dzik WH. Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells. Vox Sang 1994;66:25-32.
35. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7.
36. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
37. Couban S, Adams C, Kelton JG, Heddle N. Cycloheximide and actinomycin inhibit cytokine accumulation during platelet concentrate storage (abstract). Blood 1994;84:463a.
38. Stack G, Baril L, Napychank P, Snyder EL. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995;35:199-203.
39. Brecher ME, Pineda AA, Zylstra-Halling VW, et al. In vivo viability and functional integrity of filtered platelets. Transfusion 1990;30:718-21.
40. Sarraj-Reguieg A, Tissot JD, Hochstrasser DF, et al. Effect of prestorage leukocyte reduction on proteins of platelets obtained by apheresis. Vox Sang 1993;65:279-85.
41. Oberman HA. Controversies in transfusion medicine: should a febrile transfusion response occasion the return of the blood component to the blood bank? Con. Transfusion 1994;34:353-5.
42. Widmann F. Controversies in transfusion medicine: should a febrile transfusion response occasion the return of the blood component to the blood bank? Pro. Transfusion 1994;34:356-8.
43. Anderson KC. Leukodepleted cellular blood components for prevention of transfusion-associated graft versus host disease. Transfus Sci 1995;16:265-8.
44. Balducci L, Benson K, Lyman GH, et al. Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia. Transfusion 1993;33:665-70.